StockGlow

Roche Holding AG (RHO6.F)

Develops medicines and diagnostic tests for diseases like cancer, diabetes, and infections.

49.11+0.03%Healthcare
Compare RHO6.F with
StockGlow Score
91
Bullish
BearishBullish
1 year ago+44.0%

The outlook

RHO6.F trades near the upper end of its 52-week range and sits above both its 50- and 200-day moving averages, reflecting sustained upward positioning. The trailing P/E of 23.8 sits at a moderate premium. Analyst sentiment leans constructive based on available coverage, though specific target data wasn't provided.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range90% of the way from its 52-week low to high
Market cap
$313.03B
52-wk high
50.95
52-wk low
32.33
50-day avg
44.52
200-day avg
43.82
Trailing P/E
23.8

Similar stocks

NOTA.FNovartis AG$139.00+2.21%6MK.FMerck & Co., Inc.$116.08-1.33%4AB.FAbbVie Inc.$233.80-0.26%PFE.FPfizer Inc.$22.13+0.07%SNW.FSanofi$79.85+1.09%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy